The Doctor’s Advocate | Fourth Quarter 2020
The Back Page
Industry and Company News
A.M. Best Affirms Our A (Excellent) Ratings and Stable Outlook
A.M. Best has affirmed our financial strength rating (FSR) of A (Excellent) and the company’s long-term issuer credit rating (ICR) of a+ and stated the outlook of these ratings is stable.
These ratings apply to The Doctors Company, An Interinsurance Exchange, and its subsidiaries: TDC Specialty Insurance Company, TDC National Assurance Company, TDC Special Risks Insurance Company, and The Doctors Company Risk Retention Group, a Reciprocal Exchange.
The FSR of A is assigned only to select companies with excellent ability to meet ongoing insurance obligations. The a+ ICR is assigned to entities that have an excellent ability to meet their ongoing senior financial obligations.
“These ratings from A.M. Best reflect the strength and stability of our company, even under the economic impacts of COVID-19,” said Richard E. Anderson, MD, FACP, chairman and CEO of The Doctors Company. “Our financial strength helps us better serve our members and is integral to our mission to advance, protect, and reward the practice of good medicine.”
Leading Healthcare Executives Discuss COVID-19
At the beginning of August, we gathered healthcare leaders to discuss the most pressing issues affecting physicians, practices, and systems across the spectrum of care. Our 2020 Executive Advisory Board meeting assembled top healthcare executives for a virtual discussion of shared pandemic experiences and lessons learned that can help healthcare organizations navigate COVID-19 and beyond.
“This discussion with top healthcare leaders demonstrates the extraordinary impact not only on those battling the disease itself, but in the disruption of medical care for nearly all illness,” said Richard E. Anderson, MD, FACP, chairman and CEO. “These life and death battles are being fought by a medical workforce pushed to human limits even as many medical facilities have been rendered inaccessible and are compounded by the billions of dollars in operating losses already incurred. They rightfully seek protection against litigation, second guessing the battlefield decisions that have been required day after day after day.”
Dr. Anderson added, “Eventually this scourge will be defeated, and we look forward to continuing our dialogue with healthcare leaders on their vision for the future of medicine after COVID-19.”
Read “What Lessons Did We Learn from COVID-19?”
Latest COVID-19 Resources
As the pandemic evolves, we have continually updated our COVID-19 Resource Center for Healthcare Professionals with new articles, resources, FAQs, and downloadable sample letters.
Our resource center is just one way we are delivering on our commitment to share information and provide support during the national crisis.
Sign Up for Automatic Updates
Sign up to receive important updates by email.
The Doctor’s Advocate is published by The Doctors Company to advise and inform its members about loss prevention and insurance issues.
The guidelines suggested in this newsletter are not rules, do not constitute legal advice, and do not ensure a successful outcome. They attempt to define principles of practice for providing appropriate care. The principles are not inclusive of all proper methods of care nor exclusive of other methods reasonably directed at obtaining the same results.
The ultimate decision regarding the appropriateness of any treatment must be made by each healthcare provider considering the circumstances of the individual situation and in accordance with the laws of the jurisdiction in which the care is rendered.
The Doctor’s Advocate is published quarterly by Corporate Communications, The Doctors Company. Letters and articles, to be edited and published at the editor’s discretion, are welcome. The views expressed are those of the letter writer and do not necessarily reflect the opinion or official policy of The Doctors Company. Please sign your letters, and address them to the editor.
Fourth Quarter 2020
From the Chairman
COVID-19: A Call for Innovation and Leadership in Healthcare
Perspectives from the CMO
Could COVID-19 Bring More Patient-Centered Care to Your Practice?
An Ounce of Prevention
The Role of Pretest Probability in the Evaluation of Suspected Venous Thromboembolism
Government Relations Report
2020 Judicial Review
Dr. David Feldman Joins Foundation Board of Directors
Complimentary Telehealth Webinars
The Back Page
Industry and Company News